Market Cap (In USD)
23.9 Million
Revenue (In USD)
11.02 Million
Net Income (In USD)
-3.72 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.37-0.42
- PE
- -
- EPS
- -
- Beta Value
- 1.397
- ISIN
- FR0010609263
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Alexandre Loiseau Ph.D.
- Employee Count
- -
- Website
- https://www.maunakeatech.com
- Ipo Date
- 2013-04-15
- Details
- Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
More Stocks
-
600859Wangfujing Group Co., Ltd.
600859
-
SEII
-
CREDITACCCreditAccess Grameen Limited
CREDITACC
-
301392
-
AGUA
-
MKDWWMKD Technology Inc.
MKDWW
-
MPB
-
0201